Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - the agilia sp mc syringe pump is intended for use on adults, pediatrics, and neonatal patients for the intermittent or continuous delivery of parenteral fluids (such as solutions, colloids, parenteral nutrition), medications (such as diluted drugs, chemotherapy, anesthesia drugs), blood and blood derivatives, and medications through clinically accepted routes of administration.

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - the agilia sp tiva infusion system is intended for use on adults, pediatrics, and neonatal patients for the intermittent or continuous delivery of parenteral fluids (such as solutions, colloids, parenteral nutrition), medications (such as diluted drugs, chemotherapy, anesthesia drugs), blood and blood derivatives, and medications through clinically accepted routes of administration. it is intended for use by trained healthcare professionals in clinical healthcare facilities and in pre-hospital medical ground transportation.

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - for extended platelet storage with plasma/red blood cell collection. for use with the amicus™ separator.

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - for extended platelet storage and plasma collection, rbc collection and mnc collection.

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - to be used for the collection and filtration of aspirated bone marrow.

Israel - English - Ministry of Health

neopharm (israel) 1996 ltd - bortezomib - powder for solution for injection - bortezomib 3.5 mg/vial - bortezomib - multiple myelomabortezomib fresenius kabi is indicated for the treatment of adult patients with multiple myeloma.mantle cell lymphomabortezomib fresenius kabi for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib fresenius kabi in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - caspofungin - pdr/conc/soln for infus - 50 milligram - other mycotics for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - caspofungin - pdr/conc/soln for infus - 70 milligram - other mycotics for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - thiotepa - powder for concentrate for solution for infusion - thiotepa

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - thiotepa - powder for concentrate for solution for infusion - thiotepa